title: Migraine preventive therapy: current and emerging treatment options.
abstract: In this paper we review new treatment options for migraine prevention. We start with an overview about migraine and then briefly discuss current indications for migraine prevention and new and emerging preventive medications.
authors.affiliation: The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902-1251, USA. alanrapaport@nech.net
authors.forename: A M
authors.initials: AM
authors.lastname: Rapoport
authors.forename: M E
authors.initials: ME
authors.lastname: Bigal
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003067:Coenzymes; D004358:Drug Therapy / Q000379:methods; D006801:Humans; D000077287:Levetiracetam; D017706:Lisinopril / Q000627:therapeutic use; D008881:Migraine Disorders / Q000517:prevention & control*; D036901:Petasites / Q000502:physiology; D010879:Piperazines; D010889:Piracetam / Q000031:analogs & derivatives / Q000627:therapeutic use; D011315:Preventive Medicine / Q000639:trends*; D014230:Triazoles / Q000627:therapeutic use; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D003067:Coenzymes; D010879:Piperazines; D014230:Triazoles; D014451:Ubiquinone; D000077287:Levetiracetam; C051752:nefazodone; D017706:Lisinopril; C024989:coenzyme Q10; D010889:Piracetam